News
FDA Commissioner pick Makary pressed by Senators on vaccines
Johns Hopkins surgeon and writer Dr Martin Makary, President Donald …
20462 items found
News
Digital health firm XRHealth hits the M&A trial again
XRHealth has made its second acquisition in the space of a few …
News
Trump's NIH pick closer to role as court blocks budget cuts
President Donald Trump's nominee for NIH director, Dr Jay …
News
NICE agrees to look again at Alzheimer's drug Leqembi
Eisai will have an unprecedented third attempt to convince experts at …
Digital
GenAI and the revolution of drug development
It takes around seven years to develop a new drug and bring it to …
News
Second senior NHS England executive heads for the exit
Just days after NHS England chief executive Amanda Pritchard tendered …
News
Novo Nordisk follows Lilly into DTC obesity drug market
Novo Nordisk has launched a direct-to-consumer (DTC) option for …
Sales & Marketing
Sponsored
12 Questions with Giuseppe Accogli
Giuseppe Accogli became the Group CEO of Chiesi Pharmaceuticals in …
News
Jazz swings further into cancer with Chimerix takeover
Jazz Pharmaceuticals has reached an agreement to buy Nasdaq-listed …
News
FDA starts review of Roche's Gazyva in lupus nephritis
Roche's anti-CD20 antibody Gazyva has been on the market for more …
Sales & Marketing
Changing Faces: Pharma and biotech January 2025
Welcome to the first edition of Changing Faces for 2025. January …
News
Lawrence Tallon will lead MHRA after June Raine retires
After six years at the helm of the Medicines and Healthcare products …
News
FDA Commissioner pick Makary pressed by Senators on vaccines
President Trump's pick to lead the FDA, Martin Makary, was challenged on vaccines, the abortion pill, and FDA staffing decisions at a Senate hearing.
R&D
Sponsored
Exploring the future: Opportunities and challenges in cell a...
Rare disease treatment poses distinct challenges for physicians, patients, caregivers, and pharma companies.
R&D
Deep Dive: Research and Development 2025
Every breakthrough in medicine, every new treatment that changes lives, starts with research.
R&D
Life Sciences Industry Report - Part 7
The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.
Digital
GenAI and the revolution of drug development
Bryan Hill, life sciences chief technology officer at Cognizant, discusses how generative AI is revolutionising drug development in a new podcast.
Oncology
Life Sciences Industry Report - Part 5
Developments in the oncology space in 2024 brought hope to both industry and patients.
Partner Content
Partner Content
6th TCR-based Therapies Summit
Transforming Cell- & Biologic-based TCR Approaches
R&D
Partner Content
3rd Obesity & Weight Loss Summit
The 3rd Obesity & Weight Loss Drug Development Summit is the place to be for experts in weight loss drug development tackling the obesity epidemic.
